These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
837 related articles for article (PubMed ID: 28183701)
1. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs. He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701 [TBL] [Abstract][Full Text] [Related]
2. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells. Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061 [TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway. He Y; Zou P; Lu Y; Jia D; Li X; Yang H; Tang L; Zhu Z; Tu T; Tai S; Xiao Y; Chen M; Lu L; Zhou S J Mol Cell Cardiol; 2020 Feb; 139():1-13. PubMed ID: 31958462 [TBL] [Abstract][Full Text] [Related]
4. Increment of HFABP Level in Coronary Artery In-Stent Restenosis Segments in Diabetic and Nondiabetic Minipigs: HFABP Overexpression Promotes Multiple Pathway-Related Inflammation, Growth and Migration in Human Vascular Smooth Muscle Cells. Chen K; Chen QJ; Wang LJ; Liu ZH; Zhang Q; Yang K; Wang HB; Yan XX; Zhu ZB; Du R; Zhang RY; Shen WF; Lu L J Vasc Res; 2016; 53(1-2):27-38. PubMed ID: 27372431 [TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia. Ashino T; Yamamoto M; Yoshida T; Numazawa S Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426 [TBL] [Abstract][Full Text] [Related]
6. Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells. Wang F; Li C; Ding FH; Shen Y; Gao J; Liu ZH; Chen JW; Zhang RY; Shen WF; Wang XQ; Lu L Atherosclerosis; 2017 Dec; 267():10-18. PubMed ID: 29080545 [TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways. Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277 [TBL] [Abstract][Full Text] [Related]
8. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury. Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975 [TBL] [Abstract][Full Text] [Related]
10. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury. Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048 [TBL] [Abstract][Full Text] [Related]
11. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury. Zhang Y; Zhang Y; Li W; Wang P; Gu R; Feng Y; Wei S; Peng K; Zhang Y; Su L; Wang Q; Li D; Yang D; Wong WT; Yang Y; Ma S J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025747 [TBL] [Abstract][Full Text] [Related]
12. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609 [TBL] [Abstract][Full Text] [Related]
13. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738 [TBL] [Abstract][Full Text] [Related]
14. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation. Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796 [TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice. Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511 [TBL] [Abstract][Full Text] [Related]
16. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088 [TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice. Zhu S; Xue R; Zhao P; Fan FL; Kong X; Zheng S; Han Q; Zhu Y; Wang N; Yang J; Guan Y Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1739-47. PubMed ID: 21636806 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway. Zhang CJ; Liu C; Wang YX; Zhu N; Hu ZY; Liao DF; Qin L Vascul Pharmacol; 2019 May; 116():16-23. PubMed ID: 30822571 [TBL] [Abstract][Full Text] [Related]
19. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells. Shen Y; Li C; Zhang RY; Zhang Q; Shen WF; Ding FH; Lu L Int J Cardiol; 2017 Feb; 228():129-136. PubMed ID: 27863353 [TBL] [Abstract][Full Text] [Related]
20. Increase of ADAM10 level in coronary artery in-stent restenosis segments in diabetic minipigs: high ADAM10 expression promoting growth and migration in human vascular smooth muscle cells via Notch 1 and 3. Yang K; Lu L; Liu Y; Zhang Q; Pu LJ; Wang LJ; Zhu ZB; Wang YN; Meng H; Zhang XJ; Du R; Chen QJ; Shen WF PLoS One; 2013; 8(12):e83853. PubMed ID: 24386293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]